A NOVEL 53 KDA PROTEIN COMPLEXED WITH P210BCR-ABL IN HUMAN CHRONIC MYELOGENOUS LEUKEMIA-CELLS

被引：0
|
作者：
LI, WJ [1 ]
KLOETZER, WS [1 ]
ARLINGHAUS, RB [1 ]
机构：
[1] JOHNSON & JOHNSON BIOTECHNOL CTR INC,SAN DIEGO,CA 92121
来源：
ONCOGENE | 1988年 / 2卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：559 / 566
页数：8
相关论文
共 50 条
  • [41] p210BCR-ABL protein exists as discrete foci in the cytoplasm of CML cells as demonstrated by confocal laser scanning microscopy
    Patel, H.
    Marley, S. B.
    Kamalati, T.
    Gordon, M. Y.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 62 - 63
  • [42] Evaluation of the protective effect of human cytotoxic lymphocytes (CTL) specific for P210BCR-ABL protein in a SCID mouse model
    Renaud, M
    Langlade-Demoyen, P
    Autran, B
    Leblond, V
    HEMATOLOGY AND CELL THERAPY, 1998, 40 (02): : 87 - 87
  • [43] BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells
    Brauer, Katharina M.
    Werth, Daniela
    von Schwarzenberg, Karin
    Bringmann, Anita
    Kanz, Lothar
    Gruenebach, Frank
    Brossart, Peter
    CANCER RESEARCH, 2007, 67 (11) : 5489 - 5497
  • [44] High pH lysis allows immunoprecipitation of p210BCR-ABL in primary chronic myeloid leukaemia.
    Patel, H
    Marley, SB
    Gordon, MY
    BLOOD, 2005, 106 (11) : 297B - 297B
  • [45] BCR-ABL lacking the pleckstrin homology (PH) domain of BCR induces a more aggressive leukemia than P210BCR-ABL in a murine model of CML.
    Demehri, S
    O'Hare, T
    Wood, LJ
    Loriaux, M
    Druker, BJ
    Deininger, MW
    BLOOD, 2004, 104 (11) : 702A - 702A
  • [46] BLASTIC PRESENTATION OF CHRONIC MYELOGENOUS LEUKEMIA WITH INV(16)AND COEXPRESSION OF BOTH P210BCR/ABL1 AND P190BCR/ABL1 TRANSCRIPTS
    Zaldini, Piera
    Albertazzi, Laura
    Bellesia, Enrica
    Bonanno, Orsola
    Castellini, Gabriella
    Facchini, Luca
    Longo, Rosina
    Rinaldini, Monia
    Vecchia, Luigi
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 119 - 119
  • [47] IDENTIFICATION OF MOLECULAR VARIANTS OF P210BER-ABL IN CHRONIC MYELOGENOUS LEUKEMIA
    KURZROCK, R
    KLOETZER, WS
    TALPAZ, M
    BLICK, M
    WALTERS, R
    ARLINGHAUS, RB
    GUTTERMAN, JU
    BLOOD, 1987, 70 (01) : 233 - 236
  • [48] Synthesis, structure-activity relationship, and p210bcr-abl protein tyrosine kinase activity of novel AG 957 analogs
    Kaur, G
    Narayanan, VL
    Risbood, PA
    Hollingshead, MG
    Stinson, SF
    Varma, RK
    Sausville, EA
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (05) : 1749 - 1761
  • [49] p210BCR-ABL1- Chronic myeloid leukemia presents with monocytosis
    Wang, Xiaofei
    Wang, Fei
    Wang, Zie
    Li, Yuantang
    Wang, Devin
    Wu, Huanling
    Zhang, Bingchang
    CLINICAL CASE REPORTS, 2020, 8 (05): : 840 - 842
  • [50] Extramedullary presentation of chronic myelogenous leukemia with p190 BCR/ABL transcripts
    Yamaguchi, H
    Inokuchi, K
    Shinohara, T
    Dan, K
    CANCER GENETICS AND CYTOGENETICS, 1998, 102 (01) : 74 - 77
12345